Patent 7943593 was granted and assigned to Vertex Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.
The present invention relates to compositions comprising an apoptosis inducing anti-cancer agent and an IMPDH inhibitor. This invention also relates to methods for inducing apoptosis and for treating tumors and cancers in mammals.